UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3993) 3993
science & technology (2983) 2983
dacarbazine - administration & dosage (2899) 2899
life sciences & biomedicine (2891) 2891
female (2525) 2525
male (2485) 2485
dacarbazine - analogs & derivatives (2049) 2049
middle aged (2022) 2022
oncology (2016) 2016
adult (1976) 1976
antineoplastic combined chemotherapy protocols - therapeutic use (1943) 1943
aged (1557) 1557
temozolomide (1234) 1234
dacarbazine - therapeutic use (1162) 1162
doxorubicin - administration & dosage (1018) 1018
treatment outcome (1017) 1017
chemotherapy (944) 944
brain neoplasms - drug therapy (864) 864
combined modality therapy (816) 816
dacarbazine - adverse effects (814) 814
vincristine - administration & dosage (790) 790
melanoma - drug therapy (781) 781
bleomycin - administration & dosage (764) 764
adolescent (700) 700
hodgkin disease - drug therapy (675) 675
antineoplastic combined chemotherapy protocols - administration & dosage (667) 667
cancer (657) 657
antineoplastic combined chemotherapy protocols - adverse effects (648) 648
vinblastine - administration & dosage (642) 642
antineoplastic agents, alkylating - therapeutic use (623) 623
animals (611) 611
glioblastoma - drug therapy (595) 595
disease-free survival (537) 537
antineoplastic agents, alkylating - administration & dosage (520) 520
glioblastoma (486) 486
cell line, tumor (484) 484
prognosis (482) 482
dacarbazine - pharmacology (463) 463
drug administration schedule (452) 452
dacarbazine (451) 451
procarbazine - administration & dosage (449) 449
cyclophosphamide - administration & dosage (444) 444
neurosciences & neurology (440) 440
care and treatment (436) 436
melanoma (432) 432
prednisone - administration & dosage (429) 429
neoplasm staging (411) 411
clinical neurology (410) 410
medicine & public health (407) 407
retrospective studies (401) 401
brain neoplasms - pathology (394) 394
survival analysis (393) 393
radiotherapy (392) 392
mice (391) 391
glioma - drug therapy (390) 390
glioblastoma multiforme (388) 388
abridged index medicus (364) 364
survival rate (364) 364
skin neoplasms - drug therapy (341) 341
follow-up studies (340) 340
aged, 80 and over (338) 338
young adult (335) 335
cisplatin - administration & dosage (334) 334
gliomas (330) 330
antineoplastic agents - administration & dosage (325) 325
hodgkin disease - pathology (318) 318
melanoma - pathology (316) 316
glioblastoma - pathology (303) 303
hematology (296) 296
child (294) 294
antineoplastic agents - therapeutic use (293) 293
tumors (289) 289
brain neoplasms - therapy (286) 286
mechlorethamine - administration & dosage (286) 286
antineoplastic agents, alkylating - adverse effects (284) 284
research (284) 284
brain neoplasms - mortality (277) 277
melanoma - secondary (277) 277
hodgkin disease - radiotherapy (276) 276
drug therapy (271) 271
remission induction (267) 267
antineoplastic agents (264) 264
brain neoplasms - radiotherapy (259) 259
analysis (251) 251
surgery (246) 246
pharmacology & pharmacy (239) 239
dose-response relationship, drug (238) 238
time factors (238) 238
antimitotic agents (237) 237
chemotherapy, adjuvant (237) 237
vinblastine (236) 236
health aspects (232) 232
drug therapy, combination (228) 228
neoplasm metastasis (224) 224
skin neoplasms - pathology (220) 220
doxorubicin - adverse effects (219) 219
disease progression (216) 216
magnetic resonance imaging (214) 214
kaplan-meier estimate (213) 213
antineoplastic agents, alkylating - pharmacology (211) 211
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4024) 4024
Japanese (109) 109
German (69) 69
French (64) 64
Spanish (39) 39
Russian (35) 35
Polish (26) 26
Chinese (16) 16
Hungarian (9) 9
Italian (6) 6
Bulgarian (5) 5
Hebrew (4) 4
Norwegian (3) 3
Czech (2) 2
Dutch (2) 2
Portuguese (2) 2
Finnish (1) 1
Korean (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 09/2010, Volume 28, Issue 27, pp. 4199 - 4206
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 03/2012, Volume 30, Issue 9, pp. 907 - 913
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2018, Volume 36, Issue 4, pp. 383 - 390
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2005, Volume 23, Issue 36, pp. 9198 - 9207
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2013, Volume 31, Issue 6, pp. 684 - 691
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2009, Volume 27, Issue 35, pp. 5874 - 5880
Purpose The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared efficacy and safety of... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lomustine - adverse effects | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Glioma - radiotherapy | Glioma - genetics | Young Adult | DNA Methylation | Time Factors | Radiotherapy, Adjuvant - adverse effects | Glioma - pathology | Treatment Failure | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Dacarbazine - administration & dosage | Glioma - mortality | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Brain Neoplasms - drug therapy | Disease Progression | Disease-Free Survival | DNA Modification Methylases - genetics | Procarbazine - adverse effects | Vincristine - adverse effects | Aged | Mutation | Antineoplastic Agents, Alkylating - adverse effects | Lomustine - administration & dosage | Glioma - drug therapy | Index Medicus
Journal Article
Clinical cancer research, ISSN 1557-3265, 11/2017, Volume 23, Issue 21, pp. 6441 - 6449
Purpose: Anti-GD2 mAbs, acting via antibody-dependent cell-mediated cytotoxicity, may enhance the effects of chemotherapy. This pilot trial investigated a... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Drug-Related Side Effects and Adverse Reactions - blood | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Neuroblastoma - blood | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Dacarbazine - analogs & derivatives | Killer Cells, Natural - immunology | Camptothecin - administration & dosage | Female | Child | Neoplasm Recurrence, Local - blood | Neuroblastoma - pathology | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Dacarbazine - administration & dosage | Gangliosides - antagonists & inhibitors | Interleukin-2 Receptor alpha Subunit - blood | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cell- and Tissue-Based Therapy | Gangliosides - immunology | Disease-Free Survival | Ifosfamide - administration & dosage | Neuroblastoma - drug therapy | Adolescent | Topotecan - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Interleukin-2 - blood | Toxicity | Cytotoxicity | Malignancy | Neuroblastoma | Cerebrospinal fluid | Pain | Interleukin 2 | Surgery | Myelosuppression | Children | Natural killer cells | Antibody-dependent cell-mediated cytotoxicity | Thrombocytopenia | Immune response | Cytokines | Ifosfamide | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | Etoposide | Pharmacology | Patients | Irinotecan | Cyclophosphamide | Chemotherapy | Experimental design | Monoclonal antibodies | Carboplatin | Temozolomide | Pharmacokinetics | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 11/2012, Volume 30, Issue 33, pp. 4117 - 4123
Purpose Although the outcome of patients with HIV-related Hodgkin lymphoma (HIV-HL) has markedly improved since the introduction of combined antiretroviral... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Hodgkin Disease - pathology | Humans | Lymphoma, AIDS-Related - pathology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Young Adult | Hodgkin Disease - radiotherapy | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Lymphoma, AIDS-Related - drug therapy | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | HIV Infections - complications | Lymphoma, AIDS-Related - radiotherapy | Vincristine - adverse effects | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Index Medicus
Journal Article